Healthcare Support Services

JMDC Inc.

4483

JMDC Inc. received a Hold rating and a Yen3,600.00 price target from Tokai-Tokyo Securities analyst today.Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks JMDC Inc. has an analyst consensus of Strong Buy, with a price target consensus of Yen4,584.00.

Tip Ranks

Tokai Tokyo Financial Holdings, Inc.

JMDC Inc. (4483) was downgraded to a Hold Rating at Tokai-Tokyo Securities

JMDC (TSE:4483) has attracted investor interest due to its strong earnings per share (EPS) growth of 19% annually over the past three years. The company has also improved its EBIT margins by 4.7 percentage points to 22% and is experiencing revenue growth. Insiders hold a significant stake in the company, aligning their interests with shareholders. While JMDC shows promising growth and insider confidence, investors should assess whether the stock is undervalued before making investment decisions.

Simplywall

Here's Why JMDC (TSE:4483) Has Caught The Eye Of Investors

Tokai-Tokyo Securities analyst maintained a Buy rating on JMDC Inc. today and set a price target of Yen5,400.00.Valentine's Day Sale - 70% OffUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential The word on The Street in general, suggests a Strong Buy analyst consensus rating for JMDC Inc. with a Yen5,675.00 average price target.

Tokai-Tokyo Securities Sticks to Their Buy Rating for JMDC Inc. (4483)

6702

FJTSY

Fujitsu Japan and JMDC have announced a collaboration to enhance medical data utilization for a sustainable healthcare system in Japan. This partnership combines Fujitsu's expertise in electronic health records and advanced technologies with JMDC's anonymized medical data capabilities. The initiative aims to improve management for medical institutions and support research for pharmaceutical companies and academia. Fujitsu will provide its Dashboard 360 solution to medical institutions for free, facilitating data analysis and decision-making. The collaboration addresses challenges in Japan's healthcare system, including an aging population and rising medical costs.

Japan Corporate News

Fujitsu Limited

Fujitsu

Fujitsu Japan and JMDC announce collaboration to build sustainable healthcare system in Japan through enhanced medical data utilization

4071

In a volatile week for global markets, investors are focusing on high growth tech stocks. Three notable companies include Plus Alpha Consulting Ltd, JMDC Inc., and COVER Corporation, all demonstrating strong revenue and earnings growth. Plus Alpha Consulting is expected to grow earnings by 18.7% annually, JMDC by 21.7%, and COVER by 19.2%. Each company is investing significantly in R&D to enhance innovation and maintain competitive advantages. These firms are well-positioned for sustained growth amid market fluctuations and evolving industry dynamics.

JMDC Inc.(4483.JP)

JMDC Inc. (4483) was downgraded to a Hold Rating at Tokai-Tokyo Securities

Here's Why JMDC (TSE:4483) Has Caught The Eye Of Investors

Tokai-Tokyo Securities Sticks to Their Buy Rating for JMDC Inc. (4483)

Fujitsu Japan and JMDC announce collaboration to build sustainable healthcare system in Japan through enhanced medical data utilization

Exploring 3 High Growth Tech Stocks in the Global Market